Filana Therapeutics Inc (FLNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Operating Expenses | 779 | 1,153 | 1,451 | 750 | 1,284 |
| Operating Income | -779 | -1,153 | -1,451 | -750 | -1,284 |
| Other Income | 82 | 94 | 92 | 72 | 17 |
| Pre-tax Income | -697 | -1,059 | -1,359 | -678 | -1,267 |
| Net Income Continuous | -697 | -1,059 | -1,359 | -678 | -1,267 |
| Net Income | $-697 | $-1,059 | $-1,359 | $-678 | $-1,267 |
| EPS Basic Total Ops | -0.04 | -0.06 | -0.08 | 0.19 | -0.11 |
| EPS Basic Continuous Ops | -0.04 | -0.06 | -0.08 | 0.18 | -0.11 |
| EPS Diluted Total Ops | -0.04 | -0.06 | -0.08 | 0.19 | -0.11 |
| EPS Diluted Continuous Ops | -0.04 | -0.06 | -0.08 | 0.18 | -0.11 |
| EBITDA(a) | $-765 | $-1,140 | $-1,434 | $-733 | $-1,266 |